Search

everythinglearnresearchcommunity

for

Search:↓

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Men with Kennedy disease have less chance of hair loss.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Current research explores hair growth drugs, while future research aims for personalized treatments.

A man's baldness improved possibly due to a medication that blocks male hormones.

Zinc helps reduce the severity of depression.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Sebocytes play a key role in controlling androgen levels in human skin.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Genetics and hormones cause hair loss; finasteride treats it safely.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Hair restoration surgery has advanced, focusing on natural results and may improve further with new techniques and therapies.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.